Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MAT-2501 granted QIDP designation by the FDA

Dec. 15, 2015

ImmBio begins first-in-human studies of PnuBioVax

Dec. 15, 2015

Medshine Discovery introduces anti-HBV compounds

Dec. 14, 2015

FDA grants QIDP status to WCK-5222

Dec. 14, 2015

Gates Foundation funds research for a tapeworm vaccine

Dec. 11, 2015

Vaxart tests influenza vaccine VXA-BYW.10 in healthy adults

Dec. 11, 2015

Tangrun Pharmaceuticals develops HCV NS5A inhibitors

Dec. 10, 2015

Mexico approves Dengvaxia, world's first dengue vaccine

Dec. 10, 2015

Immunotope presents DENV universal vaccine candidates

Dec. 9, 2015

University of Pennsylvania patents rAAV expressing dual antibody constructs

Dec. 9, 2015

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...